Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin

Detalles Bibliográficos
Autores principales: Million, Matthieu, Giraud-Gatineau, Audrey, Lagier, Jean-Christophe, Parola, Philippe, Gautret, Philippe, Raoult, Didier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733546/
https://www.ncbi.nlm.nih.gov/pubmed/33316396
http://dx.doi.org/10.1016/j.tmaid.2020.101954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7733546/
https://www.ncbi.nlm.nih.gov/pubmed/33316396
http://dx.doi.org/10.1016/j.tmaid.2020.101954

Ejemplares similares